ResearcherUniversitätsmedizin GöttingenActive in the last 2 years
Muhammad Umair Latif
Matched on ORCID iD 0000-0002-6198-3069; OpenAlex author ID A5035378378. Sources: OpenAlex.
Their work
- Papers
- 2
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 21
2025: 1 paper · 2026: 1 paper
Papers 2
- GSK3βhigh/NFATc1high subtype targeting overcomes therapy resistance in pancreatic cancer through transcriptional induction of homologous recombination repair. Co-author DOI 10.1136/gutjnl-2025-336227↗
- Spatial tumor immune heterogeneity facilitates subtype co-existence and therapy response in pancreatic cancer. Co-author DOI 10.1038/s41467-024-55330-7↗
Closest collaborators
The 21 strongest of 21 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Shiv K. Singh · 2 shared papers, 2025–2026 · strength 0.39
- Paper GSK3βhigh/NFATc1high subtype targeting overcomes therapy resistance in pancreatic cancer through transcriptional induct… DOI 10.1136/gutjnl-2025-336227↗
- Paper Spatial tumor immune heterogeneity facilitates subtype co-existence and therapy response in pancreatic cancer. DOI 10.1038/s41467-024-55330-7↗
- Lukas Klein · 2 shared papers, 2025–2026 · strength 0.39
- Paper GSK3βhigh/NFATc1high subtype targeting overcomes therapy resistance in pancreatic cancer through transcriptional induct… DOI 10.1136/gutjnl-2025-336227↗
- Paper Spatial tumor immune heterogeneity facilitates subtype co-existence and therapy response in pancreatic cancer. DOI 10.1038/s41467-024-55330-7↗
- Elisabeth Heßmann · 2 shared papers, 2025–2026 · strength 0.39
- Paper GSK3βhigh/NFATc1high subtype targeting overcomes therapy resistance in pancreatic cancer through transcriptional induct… DOI 10.1136/gutjnl-2025-336227↗
- Paper Spatial tumor immune heterogeneity facilitates subtype co-existence and therapy response in pancreatic cancer. DOI 10.1038/s41467-024-55330-7↗
- Volker Ellenrieder · 2 shared papers, 2025–2026 · strength 0.39
- Paper GSK3βhigh/NFATc1high subtype targeting overcomes therapy resistance in pancreatic cancer through transcriptional induct… DOI 10.1136/gutjnl-2025-336227↗
- Paper Spatial tumor immune heterogeneity facilitates subtype co-existence and therapy response in pancreatic cancer. DOI 10.1038/s41467-024-55330-7↗
- Ulrich Sax · 1 shared paper, 2026 · strength 0.20
- Lena‐Christin Conradi · 1 shared paper, 2026 · strength 0.20
- Steven A. Johnsen · 1 shared paper, 2026 · strength 0.20
- Oliver Holger Krämer · 1 shared paper, 2026 · strength 0.20
- Zeynab Najafova · 1 shared paper, 2026 · strength 0.20
- Günter Schneider · 1 shared paper, 2026 · strength 0.20
- Argyris Papantonis · 1 shared paper, 2025 · strength 0.18
- Elisa Espinet Espinet · 1 shared paper, 2025 · strength 0.18
- Rama Khokha · 1 shared paper, 2025 · strength 0.18
- Uday Kishore · 1 shared paper, 2025 · strength 0.18
- Andreas Trumpp · 1 shared paper, 2025 · strength 0.18
- Barbara T. Grünwald · 1 shared paper, 2025 · strength 0.18
- Laura Urbach · 1 shared paper, 2025 · strength 0.18
- Kazeera Aliar · 1 shared paper, 2025 · strength 0.18
- Niklas Krebs · 1 shared paper, 2025 · strength 0.18
- Mengyu Tu · 1 shared paper, 2025 · strength 0.18
- Rebecca Diya Samuel · 1 shared paper, 2025 · strength 0.18
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.